Seikagaku Corp.

Seikagaku Corp.
Stock Exchange Tokyo Stock Exchange
EPS
JPY39.73
Market Cap
JPY74.62 B
Shares Outstanding
56.81 M
Public Float
33.1 M

Profile

Address
Marunouchi Center Building, 10/F
Tokyo Tokyo 100
Japan
Employees -
Website http://www.seikagaku.co.jp
Updated 07/08/2019
Seikagaku Corp. engages in the manufacture and sale of pharmaceuticals and medical devices specifically related to glycoconjugates. It operates through the following segments: Pharmaceuticals and Limulus Amebocyte Lysate (LAL). The Pharmaceuticals segment develops and supplies intra-articular injections for improving joint functions, cross-linked hyaluronate hydrogel for knee osteoarthritis, opthalmic surgical aids, and surgical aids for endoscopic mucosal resection.

Financials

View All
Created with Highcharts 5.0.14Seikagaku Corp.Net Income. Fiscal year is April-March. All values JPY Millions.4 7454 7453 6503 6502 5782 5781 7871 7873 9223 9222 2442 24420142015201620172018201901k2k3k4k5k
Created with Highcharts 5.0.14Seikagaku Corp.Sales/Revenue. Fiscal year is April-March. All values JPY Millions.29 61429 61429 52229 52230 96230 96229 58929 58930 17530 17528 38428 384201420152016201720182019010k20k30k40k

Ken Mizutani
President & Representative Director
Toshinori Yagura
Senior Managing Representative Director